GW-501516 (Cardarine) + MK-2866 (Ostarine) + S-4 (Andarine) @ 30ml oral liquid delivery.
99%+ Purity stabilized in solution.
Buy SARMs Triple Pack Combo from Southern SARMs for the highest quality available and receive free shipping on all orders over $200!
These three compounds are often studied during the same research efforts both independent of one another as well as in combination. Research has proven that these compounds create synergy and amplify the target affects, effectively the math becomes “1 + 1 = 3”.
Combination of compounds demonstrate increased lean body mass and fat loss in study results Form a synergistic effect and amplify target study values Not for human consumption
Ostarine belongs to a class of chemicals know as SARMs or selective androgen receptor modulators. SARMs create selective anabolic activity at certain androgen receptors. In comparison to testosterone and other anabolic steroids, the advantage of SARMs, is they do not have androgenic activity in non-skeletal muscle tissues (less side effects). Ostarine is effective in maintaining and increasing lean body mass. SARMS such as Ostarine cannot be aromatized, concentrating all their effects to AR binding and not to metabolic conversion into androgens/estrogens.
Andarine (S-4) is an selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy. Compared to testosterone and other anabolic steroids and pro hormones, the advantage of SARMs such as S-4 is that they do not have androgenic activity in non-skeletal-muscle tissues. S4 was designed for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound. As an orally active partial agonist for androgen receptors, S-4 is effective in not only maintaining lean mass but actually increasing it.
GW-501516 (GW1516, Endurobol or GSK-516) acts as a PPAR-β modulator. GW 501516 activates AMP-activated protein kinase and stimulates glucose uptake in skeletal muscle tissue, and GW-501516 has been demonstrated to reverse metabolic abnormalities in obese men with pre-diabetic metabolic syndrome, most likely by stimulating fatty acid oxidation. It has been proposed as a potential treatment for obesity and related conditions, especially when used in conjunction with a synergistic compound AICAR, as the combination has been shown to significantly increase exercise endurance in animal studies.